Antiepileptics May Get Class Suicide Warning Though Classwide Risk Was Not Seen
This article was originally published in The Pink Sheet Daily
Three of the 11 drugs studied did not exhibit a strong suicidality signal, but FDA says the data merit a “black box” warning for all.
You may also be interested in...
Committee agrees anti-epileptics demonstrate a risk signal for suicidality, but sees potential for more harm than good in adding black box.
Drug makers need to continue investing in early-stage research to unveil the next $1 billion-plus drug, panelists at the Argyle conference agree.